News Sentiment

CYCN sentiment intelligence

Cyclerion Therapeutics Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 50 Balanced news tone 28 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 3.84 Week of 10 Jul 2026
Weighted tone 50/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

79/100 classification confidence.

Company focus 20

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend active

+11.8% over one week, +18.0% over four weeks, trend active, and materially above fair value.

Latest direct headline Negative

Cyclerion Therapeutics (CYCN) Edges Lower, Testing Key Support Amid Low Volume - New Highs New Lows

Market Reaction

Price moving ahead of tone

58/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 79/100 classification
One-week reaction 11.8% Price confirming higher
Trend fit Trend active 18.0% over four weeks
Fair value 37.5% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 4
Neutral 22
Negative 2

Relevance

Why the article matched

Direct first
Direct company coverage 20
Industry context 8
Sector context 0

Sources

Coverage mix

Publishers
Market source 6
Stock Titan 3
timothysykes.com 3
simplywall.st 2
Quiver Quantitative 2
dars.gov.et 1
DonanımHaber 1
International Business Times Australia 1

Event Lens

What the news is about

Classified themes
Market update 14
Earnings 8
Deals and strategy 6

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-28 of 28